740 related articles for article (PubMed ID: 20644256)
1. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.
Sun S; Sprenger CC; Vessella RL; Haugk K; Soriano K; Mostaghel EA; Page ST; Coleman IM; Nguyen HM; Sun H; Nelson PS; Plymate SR
J Clin Invest; 2010 Aug; 120(8):2715-30. PubMed ID: 20644256
[TBL] [Abstract][Full Text] [Related]
2. Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.
Peacock SO; Fahrenholtz CD; Burnstein KL
Mol Endocrinol; 2012 Dec; 26(12):1967-79. PubMed ID: 23023561
[TBL] [Abstract][Full Text] [Related]
3. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.
Hu R; Lu C; Mostaghel EA; Yegnasubramanian S; Gurel M; Tannahill C; Edwards J; Isaacs WB; Nelson PS; Bluemn E; Plymate SR; Luo J
Cancer Res; 2012 Jul; 72(14):3457-62. PubMed ID: 22710436
[TBL] [Abstract][Full Text] [Related]
4. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
[TBL] [Abstract][Full Text] [Related]
5. AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancer.
Liu G; Sprenger C; Sun S; Epilepsia KS; Haugk K; Zhang X; Coleman I; Nelson PS; Plymate S
Neoplasia; 2013 Sep; 15(9):1009-17. PubMed ID: 24027426
[TBL] [Abstract][Full Text] [Related]
6. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.
Mostaghel EA; Morgan A; Zhang X; Marck BT; Xia J; Hunter-Merrill R; Gulati R; Plymate S; Vessella RL; Corey E; Higano CS; Matsumoto AM; Montgomery RB; Nelson PS
PLoS One; 2014; 9(10):e111545. PubMed ID: 25356728
[TBL] [Abstract][Full Text] [Related]
8. Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer.
Yu Z; Chen S; Sowalsky AG; Voznesensky OS; Mostaghel EA; Nelson PS; Cai C; Balk SP
Clin Cancer Res; 2014 Mar; 20(6):1590-600. PubMed ID: 24449822
[TBL] [Abstract][Full Text] [Related]
9. mRNA expressions of androgen receptor and its variants in matched hormone-sensitive and castration-resistant prostate cancer.
Park HK; Lim SD; Kwon GY
Scand J Urol; 2019 Dec; 53(6):365-371. PubMed ID: 31809622
[No Abstract] [Full Text] [Related]
10. Isoform-specific Activities of Androgen Receptor and its Splice Variants in Prostate Cancer Cells.
Nagandla H; Robertson MJ; Putluri V; Putluri N; Coarfa C; Weigel NL
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33300995
[TBL] [Abstract][Full Text] [Related]
11. AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.
Li Y; Hwang TH; Oseth LA; Hauge A; Vessella RL; Schmechel SC; Hirsch B; Beckman KB; Silverstein KA; Dehm SM
Oncogene; 2012 Nov; 31(45):4759-67. PubMed ID: 22266865
[TBL] [Abstract][Full Text] [Related]
12. Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival.
Hörnberg E; Ylitalo EB; Crnalic S; Antti H; Stattin P; Widmark A; Bergh A; Wikström P
PLoS One; 2011 Apr; 6(4):e19059. PubMed ID: 21552559
[TBL] [Abstract][Full Text] [Related]
13. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
Kregel S; Kiriluk KJ; Rosen AM; Cai Y; Reyes EE; Otto KB; Tom W; Paner GP; Szmulewitz RZ; Vander Griend DJ
PLoS One; 2013; 8(1):e53701. PubMed ID: 23326489
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines.
Li Y; Chan SC; Brand LJ; Hwang TH; Silverstein KA; Dehm SM
Cancer Res; 2013 Jan; 73(2):483-9. PubMed ID: 23117885
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
16. The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells.
Lu J; Lonergan PE; Nacusi LP; Wang L; Schmidt LJ; Sun Z; Van der Steen T; Boorjian SA; Kosari F; Vasmatzis G; Klee GG; Balk SP; Huang H; Wang C; Tindall DJ
J Urol; 2015 Feb; 193(2):690-8. PubMed ID: 25132238
[TBL] [Abstract][Full Text] [Related]
17. ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors.
Yamashita S; Lai KP; Chuang KL; Xu D; Miyamoto H; Tochigi T; Pang ST; Li L; Arai Y; Kung HJ; Yeh S; Chang C
Neoplasia; 2012 Jan; 14(1):74-83. PubMed ID: 22355276
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.
Sharp A; Coleman I; Yuan W; Sprenger C; Dolling D; Rodrigues DN; Russo JW; Figueiredo I; Bertan C; Seed G; Riisnaes R; Uo T; Neeb A; Welti J; Morrissey C; Carreira S; Luo J; Nelson PS; Balk SP; True LD; de Bono JS; Plymate SR
J Clin Invest; 2019 Jan; 129(1):192-208. PubMed ID: 30334814
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy.
Cao B; Qi Y; Zhang G; Xu D; Zhan Y; Alvarez X; Guo Z; Fu X; Plymate SR; Sartor O; Zhang H; Dong Y
Oncotarget; 2014 Mar; 5(6):1646-56. PubMed ID: 24722067
[TBL] [Abstract][Full Text] [Related]
20. MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand.
Liu G; Sprenger C; Wu PJ; Sun S; Uo T; Haugk K; Epilepsia KS; Plymate S
Oncotarget; 2015 Jan; 6(1):288-304. PubMed ID: 25481872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
